4.6 Article

SOX17 expression and its down-regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma

期刊

HISTOPATHOLOGY
卷 76, 期 3, 页码 383-393

出版社

WILEY
DOI: 10.1111/his.13980

关键词

cervical (pre)neoplasia; keratins; reserve cells; SOX2; SOX17; squamocolumnar junction; transformation zone; uterine cervix

向作者/读者索取更多资源

Aims SOX17 expression has not been studied in glandular lesions of the uterine cervix like adenocarcinoma in situ (AIS) and invasive adenocarcinomas (AdC), whereas SOX17 promoter CpG island methylation has been reported. Therefore, the aim of this study was to relate the topographical distribution of SOX17 expression and SOX17 methylation status to each other, and to SOX2 expression, human papillomavirus (HPV) type, and physical status of the virus. Methods and results Immunohistochemistry was used in 45 cases to assess expression of SOX17 and SOX2. SOX17 promoter methylation was determined in 25 cases by means of bisulphite conversion and methylation-specific polymerase chain reaction. SOX17 and SOX2 showed a mutually exclusive expression pattern in normal epithelium, with a sharp delineation in the squamocolumnar junction. SOX17 was found in endocervical columnar and reserve cells, whereas SOX2 was exclusively found in squamous epithelium. In both glandular lesions and cases with coexisting glandular and squamous intraepithelial components, a complex combination of SOX17 and SOX2 expression patterns was seen and mutually exclusive expression was lost. Frequently, gain of expression of SOX2 was found and expression of SOX17 was lost. Methylation of the CpG island in the SOX17 promoter was shown to be strongly associated with loss of expression of SOX17 (P = 0.0016). Conclusions In this study, we show for the first time a direct correlation between the topographical distribution of SOX17 expression and the methylation status of its gene promoter. This explains the heterogeneity of SOX17 expression in the glandular lesions of the cervix. No correlation was found between HPV type and physical status of the virus on the one hand and methylation status on the other.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pathology

Molecular pathology of urogenital tumors Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference

Oliver Hommerding, Yves Allory, Pedram Argani, Tarek A. Bismar, Lukas Bubendorf, Sofia Canete-Portillo, Alcides Chaux, Ying-Bei Chen, Liang Cheng, Antonio L. Cubilla, Lars Egevad, Anthony J. Gill, David J. Grignon, Arndt Hartmann, Ondrej Hes, Muhammad T. Idrees, Chia-Sui Kao, Margaret A. Knowles, Leendert H. J. Looijenge, Tamara L. N. Lota, Colin C. Pritchard, Mark A. Rubin, Scott A. Tom Fins, Theodorus H. Van der Kwast, Elsa F. Velazquez, Joshua Warrick, Sean R. Williamson, Glen Kristiansen

Summary: This article summarizes the consensus conference held by the International Society of Urogenital Pathology in March 2019 on molecular diagnostics of genitourinary tumors. Five working groups presented the research results and background information, and developed diagnostic action recommendations, with 66% agreement among conference participants defined as consensus.

PATHOLOGE (2021)

Review Oncology

Treatment and Survival of Malignant Extracranial Germ Cell Tumours in the Paediatric Population: A Systematic Review and Meta-Analysis

Caroline C. C. Hulsker, Issam el Mansori, Marta Fiocco, Jozsef Zsiros, Marc H. W. Wijnen, Leendert H. J. Looijenga, Annelies M. C. Mavinkurve-Groothuis, Alida F. W. van der Steeg

Summary: Germ cell tumours are a heterogeneous group of neoplasms occurring predominantly in midline locations from birth to late adulthood. Despite the heterogeneity, subpopulations with inferior survival outcomes have been identified, potentially benefiting from future research and more individualised treatment strategies. This systematic review highlights the impact of tumour location on stage at presentation, treatment modalities, and survival data, emphasizing the importance of tailored approaches to improve outcomes.

CANCERS (2021)

Review Urology & Nephrology

Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review

Ricardo Leao, Maarten Albersen, Leendert H. J. Looijenga, Torgrim Tandstad, Christian Kollmannsberger, Matthew J. Murray, Stephane Culine, Nicholas Coleman, Gazanfer Belge, Robert J. Hamilton, Klaus-Peter Dieckmann

Summary: Circulating microRNA levels, especially miR-371a-3p, show promise for clinical use in testicular germ cell tumors, with high sensitivity and specificity in various clinical scenarios, potentially aiding in clinical decision-making.

EUROPEAN UROLOGY (2021)

Article Biochemistry & Molecular Biology

The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors

Dennis M. Timmerman, Thomas F. Eleveld, Ad J. M. Gillis, Carlijn C. Friedrichs, Sanne Hillenius, Tessa L. Remmers, Sruthi Sriram, Leendert H. J. Looijenga

Summary: Germ cell tumors (GCTs) have varying responses to platinum-based chemotherapy depending on their anatomical origin, with mediastinal GCTs showing resistance compared to testicular GCTs. TP53 mutations may play a role in causing cisplatin resistance in mediastinal GCTs, suggesting a potential target for treatment. The study provides insights into the underlying mechanisms of TP53 mutant and mediastinal GCTs for alternative treatment approaches.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Humanised Mice and Immunodeficient Mice (NSG) Are Equally Sensitive for Prediction of Stem Cell Malignancy in the Teratoma Assay

Monika Bialecka, Joaquin Montilla-Rojo, Bernard A. J. Roelen, Ad J. Gillis, Leendert H. J. Looijenga, Daniela. C. F. Salvatori

Summary: This study compared tumour development in humanized immune system (HIS) mice and immunocompromised mice (NSG) after injection of cell lines, revealing that the HIS mouse model is comparable to, but not more sensitive than, the NSG immunodeficient model for studying the malignancy of stem cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors

Dennis M. Timmerman, Thomas F. Eleveld, Sruthi Sriram, Lambert C. J. Dorssers, Ad J. M. Gillis, Silvia Schmidtova, Katarina Kalavska, Harmen J. G. van de Werken, Christoph Oing, Friedemann Honecker, Michal Mego, Leendert H. J. Looijenga

Summary: In male type II germ cell tumors (GCTs), cisplatin resistance and poor clinical outcome are strongly associated with the status of 3p25.3. Genomic profiling based on this gene can help improve risk stratification in male patients with type II GCT.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

The Occurrence of MET Ectodomain Shedding in Oral Cancer and Its Potential Impact on the Use of Targeted Therapies

Maria J. De Herdt, Berdine van der Steen, Robert J. Baatenburg de Jong, Leendert H. J. Looijenga, Senada Koljenovic, Jose A. Hardillo

Summary: Head and neck cancer, particularly oral cancer, is a common type of cancer with a low survival rate. Targeted therapies that focus on the MET protein have gained attention, but the lack of companion diagnostics complicates treatment. Shedding of the ectodomain of MET and its association with poor prognosis in oral squamous cell carcinoma highlight the importance of investigating MET-EC- and incorporating it into companion diagnostics.

CANCERS (2022)

Article Cell Biology

SOX2 expression in the pathogenesis of premalignant lesions of the uterine cervix: its histo-topographical distribution distinguishes between low- and high-grade CIN

Jobran M. Moshi, Monique Ummelen, Jos L. Broers, Frank Smedts, Koen K. Van de Vijver, Jack P. M. Cleutjens, Rogier J. N. T. M. Litjens, Frans C. S. Ramaekers, Anton H. N. Hopman

Summary: SOX2 expression is increased in high-grade cervical intraepithelial neoplasia and cervical squamous cell carcinoma compared to normal cervical epithelium. The expression pattern of SOX2 changes during the progression of CIN, with increased expression in the intermediate/superficial compartment. A specific expression pattern is found in CIN2 and CIN3, which is significantly associated with CIN3 and contains HPV-positive cells in the basal/parabasal compartment. This study provides new insights into the pathogenesis and dynamics of premalignant cervical lesions and the target cells for HPV infection.

HISTOCHEMISTRY AND CELL BIOLOGY (2022)

Article Endocrinology & Metabolism

Familial Male-limited Precocious Puberty (FMPP) and Testicular Germ Cell Tumors

Cezanne D. Kooij, Annelies M. C. Mavinkurve-Groothuis, Idske C. L. Kremer Hovinga, Leendert H. J. Looijenga, Tuula Rinne, Jacques C. Giltay, Laetitia M. O. de Kort, Aart J. Klijn, Ronald R. de Krijger, Annemarie A. Verrijn Stuart

Summary: This study reports the development of malignant testicular germ cell tumors in two young adult males with familial male-limited precocious puberty (FMPP) due to LHCGR pathogenic variants. The study also investigates the potential link between FMPP and testicular tumors. The results suggest that FMPP might increase the risk of developing testicular GCTs in early adulthood.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Oncology

Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma

Kaylee M. M. Keller, Thomas F. F. Eleveld, Linda Schild, Kim van den Handel, Marlinde van den Boogaard, Vicky Amo-Addae, Selma Eising, Kimberley Ober, Bianca Koopmans, Leendert Looijenga, Godelieve A. M. Tytgat, Bauke Ylstra, Jan J. J. Molenaar, M. Emmy M. Dolman, Sander R. R. van Hooff

Summary: Neuroblastoma, a common solid tumor in children, remains challenging to treat with low survival rates, particularly in high-risk patients. Chromosome 11q loss and MYCN amplification are genetic subsets associated with poor outcomes, and checkpoint kinase 1 (CHK1) is identified as a potential therapeutic target for 11q deleted neuroblastoma. Additionally, MYCN amplification may serve as a biomarker for CHK1 inhibition, independent of 11q loss.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Expression of Intermediate Filaments in the Developing Testis and Testicular Germ Cell Cancer

Maria E. Camacho-Moll, Leendert H. J. Looijenga, Roland Donat, Chitranjan J. Shukla, Anne Jorgensen, Rod T. Mitchell

Summary: Testicular germ cell cancer (TGCC) is a common type of cancer in men, originating from immature germ cells. Sertoli cells, which are important for the survival and development of these germ cells, are also immature in TGCC. This study investigated the expression of desmin and cytokeratin proteins in Sertoli cells and found that desmin is not useful for detecting immature Sertoli cells, while cytokeratin may be useful for diagnosing impaired testicular development and pre-invasive TGCC.

CANCERS (2022)

Article Endocrinology & Metabolism

Undetectable anti-Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis

Sabine E. Hannema, Katja P. Wolffenbuttel, Yolande van Bever, Hennie T. Bruggenwirth, Sjoerd A. A. van den Berg, Remko Hersmus, J. Wolter Oosterhuis, Leendert H. J. Looijenga

Summary: Individuals with 45,X/46,XY or 46,XY gonadal dysgenesis have an increased risk of germ cell malignancies. This study aimed to determine if undetectable preoperative serum anti-Mullerian hormone (AMH) and inhibin B can predict the absence of germ cells or (pre)malignant conditions. The results suggest that undetectable AMH and inhibin B cannot reliably predict the absence of germ cells in individuals with gonadal dysgenesis. Rating: 8/10.

CLINICAL ENDOCRINOLOGY (2023)

Review Biochemistry & Molecular Biology

Teratoma Assay for Testing Pluripotency and Malignancy of Stem Cells: Insufficient Reporting and Uptake of Animal-Free Methods-A Systematic Review

Joaquin Montilla-Rojo, Monika Bialecka, Kimberley E. E. Wever, Christine L. L. Mummery, Leendert H. J. Looijenga, Bernard A. J. Roelen, Daniela C. F. Salvatori

Summary: Pluripotency is crucial for assessing stem cells, but there is a lack of standardization in the teratoma assay and ethical concerns about animal use. In vitro alternatives have been developed, but their use and malignancy testing remain limited. The teratoma assay is still preferred for safety assessment, highlighting the need for an in vitro assay for testing stem cell malignancy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Multidisciplinary Sciences

Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence

Lin Xu, Joshua L. Pierce, Angelica Sanchez, Kenneth S. Chen, Abhay A. Shukla, Nicholas J. Fustino, Sarai H. Stuart, Aditya Bagrodia, Xue Xiao, Lei Guo, Mark D. Krailo, Furqan Shaikh, Deborah F. Billmire, Farzana Pashankar, Jessica Bestrashniy, J. Wolter Oosterhuis, Ad J. M. Gillis, Yang Xie, Lisa Teot, Jaume Mora, Jenny N. Poynter, Dinesh Rakheja, Leendert H. J. Looijenga, Bruce W. Draper, A. Lindsay Frazier, James F. Amatruda

Summary: This study provides multi-omics profiling of malignant germ cell tumors (GCTs) across different age groups, showing that the WNT signaling pathway is activated in GCTs and is associated with poor clinical outcomes.

NATURE COMMUNICATIONS (2023)

Review Oncology

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Patient Characteristics, Treatment, and Outcome-A Systematic Review

Francis S. P. L. Wens, Caroline C. C. Hulsker, Marta Fiocco, Jozsef Zsiros, Stephanie E. Smetsers, Ronald R. de Krijger, Alida F. W. van der Steeg, Ronald P. Zweemer, Inge O. Baas, Eva Maria Roes, Leendert H. J. Looijenga, Cornelis G. Gerestein, Annelies M. C. Mavinkurve-Groothuis

Summary: Small-cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and aggressive ovarian cancer with a poor prognosis. More research and international collaboration are needed to improve the treatment and outcome for SCCOHT patients. Mutations in the SMARCA4 gene play a crucial role in accurate diagnosis and may lead to new treatment options.

CANCERS (2023)

暂无数据